It’s been an uneventful year for diagnostic chain Thyrocare Technologies. From a high of Rs.682 in September 2018, its stock price hit an all-time low of Rs.425 in May 2019. The stock had hit its all-time high of Rs.780 in April, 2017 post its IPO at Rs.446 a year earlier. Mirroring investor sentiment, A Velumani, founder and CEO, noted in the company’s Q4FY19 investor meet that FY19 was a year of subdued growth.
Thyrocare’s quest to boost its topline growth in FY19 meant the company had to “sacrifice” its profitability. It lowered the prices of its popular heal